2i3h: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="2i3h" size="450" color="white" frame="true" align="right" spinBox="true" caption="2i3h, resolution 1.62Å" /> '''Structure of an ML-... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2i3h.gif|left|200px]]<br /> | [[Image:2i3h.gif|left|200px]]<br /><applet load="2i3h" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="2i3h" size=" | |||
caption="2i3h, resolution 1.62Å" /> | caption="2i3h, resolution 1.62Å" /> | ||
'''Structure of an ML-IAP/XIAP chimera bound to a 4-mer peptide (AVPW)'''<br /> | '''Structure of an ML-IAP/XIAP chimera bound to a 4-mer peptide (AVPW)'''<br /> | ||
==Overview== | ==Overview== | ||
Designed second mitochondrial activator of caspases (Smac) mimetics based | Designed second mitochondrial activator of caspases (Smac) mimetics based on an accessible [7,5]-bicyclic scaffold bind to and antagonize protein interactions involving the inhibitor of apoptosis (IAP) proteins, X-chromosome-linked IAP (XIAP), melanoma IAP (ML-IAP), and c-IAPs 1 and 2 (cIAP1 and cIAP2). The design rationale is based on a combination of phage-panning data, peptide binding studies, and a survey of potential isosteres. The synthesis of two scaffolds is described. These compounds bind the XIAP-baculoviral IAP repeat 3 (BIR3), cIAP1-BIR3, cIAP2-BIR3, and ML-IAP-BIR domains with submicromolar affinities. The most potent Smac mimetic binds the cIAP1-BIR3 and ML-IAP-BIR domains with a K i of 50 nM. The X-ray crystal structure of this compound bound to an ML-IAP/XIAP chimeric BIR domain protein is compared with that of a complex with a phage-derived tetrapeptide, AVPW. The structures show that these compounds bind to the Smac-binding site on ML-IAP with identical hydrogen-bonding patterns and similar hydrophobic interactions. Consistent with the structural data, coimmunoprecipitation experiments demonstrate that the compounds can effectively block Smac interactions with ML-IAP. The compounds are further demonstrated to activate caspase-3 and -7, to reduce cell viability in assays using MDA-MB-231 breast cancer cells and A2058 melanoma cells, and to enhance doxorubicin-induced apoptosis in MDA-MB-231 cells. | ||
==About this Structure== | ==About this Structure== | ||
2I3H is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN, LI, BTB and EDO as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | 2I3H is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=LI:'>LI</scene>, <scene name='pdbligand=BTB:'>BTB</scene> and <scene name='pdbligand=EDO:'>EDO</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2I3H OCA]. | ||
==Reference== | ==Reference== | ||
| Line 14: | Line 13: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Fairbrother, W | [[Category: Fairbrother, W J.]] | ||
[[Category: Franklin, M | [[Category: Franklin, M C.]] | ||
[[Category: BTB]] | [[Category: BTB]] | ||
[[Category: EDO]] | [[Category: EDO]] | ||
| Line 27: | Line 26: | ||
[[Category: zinc binding]] | [[Category: zinc binding]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:48:41 2008'' | ||